Xinxiang Pharmaceutical Co., Ltd. (hereinafter referred to as the company), located at No. 16 Jianwen Road, Industrial agglomeration District, Yanjin County, Xinxiang City, is a wholly owned subsidiary of Xinxiang Tuoxin Pharmaceutical Co., Ltd. (stock code: 301089).
Relying on the strong technical research and development strength of the parent company and the complete product chain of pharmaceutical intermediates, the company has made great progress in research and development, production and sales. It has gradually grown into a company specializing in chemical synthesis, fermentation of nucleoside (acid) raw materials and pharmaceutical intermediates.
Xinxiang Pharmaceutical implements GMP management in all aspects, and a number of products have passed GMP certification or on-site verification.
At the same time, the company actively promotes the approval, registration and registration of all kinds of products at home and abroad.
Domestically, a variety of APIs have been approved or registered, including Azvudine, sodium citicoline, cytarabine hydrochloride, adenosine monophosphate, inosine, ribavirin, acyclovir, etc.; in foreign countries, some of the company's products have been registered in DMF in India and Uzbekistan.
Our company always takes people's health as the center, adheres to the principles of risk management, whole-process control and social co-governance, establishes a scientific and rigorous quality management system, improves the quality of drugs in all directions, and ensures the safety, effectiveness and accessibility of drugs; strictly abide by laws and regulations to ensure that the whole process information is true, accurate, complete and traceable.
We continues to provide quality products and services to customers at home and abroad, and sincerely welcome the guidance and cooperation of friends from all walks of life!
